16. 10. 2017 | krebs:hilfe!
CheckMate 032: Efficacy of nivolumab is enhanced in SCLC patients with high TMB with or without Ipilimumab
New research showed that among small cell lung cancer (SCLC) patients, the efficacy of using nivolumab with or without (±) ipilimumab was enhanced among those with a high tumor mutation burden (TMB).